Erratum: A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443)
Torsak Bunupuradah, Ploenchan Chetchotisakd, Jintanat Ananworanich, Warangkana Munsakul, Supunnee Jirajariyavej, Pacharee Kantipong, Wisit Prasithsirikul, Somnuek Sungkanuparph, Chureeratana Bowonwatanuwong, Virat Klinbuayaem, Stephen J. Kerr, Jiratchaya Sophonphan, Sorakij Bhakeecheep, Bernard Hirschel, Kiat Ruxrungtham Erratum: A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443). Antiviral Therapy. Vol.17, No.7 (2012), 1389-1390. doi:10.3851/IMP2452 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/15122
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Erratum: A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443)
